Dr David Lepp

https://www.nature.com/articles/s41577-020-00458-y?utm_source=pocket-app&utm_medium=share

"Given the lack of self-reactivity seen with the majority of SARS-CoV-2-neutralizing monoclonal antibodies, the development of efficacious and safe vaccines is clearly possible. However, ongoing vaccination trials should closely investigate the induction of potential tissue-reactive antibodies and related clinical signs."

Do cross-reactive antibodies cause neuropathology in COVID-19? Neurological symptoms are increasingly being observed in patients with COVID-19; this Comment article considers whether cross-reactive antibodies might contribute to the pathology associated with SARS-CoV-2 infection.

Answers to your important questions based on science, not politics or belief systems:

Dr Vojdani Coronavirus 050820

Deep Squat Perfected